Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Common bone-loss drug Fosamax may guard against new-onset diabetes, national study finds
By
Alicia Lasek
Oct 04, 2021
Participants taking alendronate were 36% less likely to have new-onset type 2 diabetes than their peers who did not take the drug, according to a large, 10-year study in Denmark.
Clinical briefs for Monday, Oct. 4
By
Alicia Lasek
Oct 04, 2021
Patients on chemotherapy likely not fully protected by COVID vaccine … Unauthorized nursing home COVID tests lead to audit demands … ‘Game-changing’ wellness model takes person-centric approach...
Long-term symptoms more likely to follow COVID-19 than influenza, study finds
By
Alicia Lasek
Oct 01, 2021
The results suggest that these effects are linked directly to SARS-CoV-2 infection and are not just a general consequence of viral infection, say investigators from University of Oxford, in the United...
CMS program had unintended outcome for Black residents with dementia, study suggests
By
Alicia Lasek
Oct 01, 2021
The rate of schizophrenia diagnoses rose significantly for Black nursing home residents with dementia after the CMS National Partnership to Improve Dementia Care launched in 2012, a new analysis finds.
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
By
Alicia Lasek
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.
Clinical briefs for Friday, Oct 1
By
Alicia Lasek
Oct 01, 2021
REGEN-COV antibody treatment cuts severe COVID risk at half dose, late-stage trial results show … Drug improves memory and function for those with dementia and ‘silent seizures’ … Depression relapse...
FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.
Prevnar 20 can be safely administered to seniors along with a flu shot, clinical trial finds
By
Alicia Lasek
Sep 30, 2021
Study participants’ immune responses to the newly approved pneumonia vaccine and an adjuvanted flu drug were the same, whether the drugs were given together or a month apart, the drugmaker reports. And...
No unexpected pattern of adverse booster shot reactions reported by CDC app users
By
Alicia Lasek
Sep 30, 2021
Most v-safe app respondents reported mild to moderate, transient reactions, usually the day after vaccination, CDC investigators say. Sixty percent of respondents were between the ages of 50 and 74.